Description
Exelon Gelcaps (rivastigmine) are a prescription medication primarily used in the management of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. Rivastigmine is classified as a cholinesterase inhibitor, which means it works by increasing levels of acetylcholine, a neurotransmitter crucial for memory and cognitive function. By inhibiting the enzyme that breaks down acetylcholine, Exelon Gelcaps help improve communication between nerve cells, potentially enhancing cognitive abilities and daily functioning in patients experiencing cognitive decline.
The gelcap formulation offers a convenient delivery method that allows for easy ingestion and consistent absorption of the medication. This formulation not only aids patient compliance but also ensures that the therapeutic effects of rivastigmine are realized in a timely manner, providing patients with a better quality of life.